Form 4: Scholar Rock Director Srinivas Akkaraju Reports Significant Equity Compensation Awards

Scholar Rock Holding Corp. Director Srinivas Akkaraju reported the acquisition of 7,632 Restricted Stock Units and 9,206 stock options as part of his compensation, alongside existing direct and indirect holdings.

Summary

• Srinivas Akkaraju, a Director of Scholar Rock Holding Corp (SRRK), reported changes in his beneficial ownership through a Form 4 filing.
• He acquired 7,632 Restricted Stock Units (RSUs) on May 22, 2025, which are set to vest on the earlier of June 15, 2026, or the date of the Issuer's next Annual Meeting, contingent on his continued service.
• Additionally, Mr. Akkaraju acquired 9,206 stock options with an exercise price of $30.46 on May 22, 2025, which will vest and become fully exercisable on the earlier of the first anniversary of the grant date or the date of the Issuer's next Annual Meeting, also subject to continued service.
• Following these transactions, Mr. Akkaraju directly beneficially owns 21,132 securities, comprising 13,500 shares of Common Stock and 7,632 RSUs.
• He also indirectly beneficially owns 5,612,896 shares of Common Stock through Samsara BioCapital, L.P., where he serves as a managing member of the general partner, disclaiming beneficial ownership except to the extent of his pecuniary interest.

Sentiment

Score: 7

Explanation: The filing indicates a routine grant of equity compensation to a director, which is generally a positive sign of continued alignment between management/board and shareholder interests. It reflects standard corporate governance practices and does not suggest any immediate negative implications for the company.

Positives

• The grant of Restricted Stock Units and stock options to a director aligns their financial interests with the long-term performance and shareholder value creation of Scholar Rock Holding Corp.
• Equity compensation is a standard practice that helps attract and retain experienced board members, indicating continued commitment to the company's strategic direction.

Risks

• The vesting of the 7,632 Restricted Stock Units and 9,206 stock options is contingent upon Mr. Akkaraju's continued service to the Issuer through the specified vesting dates, meaning forfeiture if service ceases.
• The value realized from the stock options is dependent on the future market price of Scholar Rock Holding Corp. common stock exceeding the exercise price of $30.46.

Future Outlook

The vesting schedules for the newly acquired Restricted Stock Units and stock options extend into 2026 and 2035 respectively, indicating a long-term alignment of the director's interests with the company's future performance and strategic objectives.

Industry Context

This filing represents a routine disclosure of insider equity compensation, a common practice in the biotechnology sector. Companies in this industry frequently use equity grants to attract and retain key talent, including directors, and to align their incentives with long-term shareholder value creation, reflecting a standard approach to corporate governance and compensation.

Comparison to Industry Standards

• The grant of Restricted Stock Units and stock options as part of director compensation is a standard practice across the biotechnology and pharmaceutical industries, comparable to compensation structures seen in companies like Biogen Inc. or Vertex Pharmaceuticals Inc.
• This mechanism is widely used to incentivize long-term performance and retention, aligning director interests with shareholder returns, and is consistent with global benchmarks for executive and board compensation in growth-oriented sectors.

Related Party Transactions

• Srinivas Akkaraju indirectly beneficially owns 5,612,896 shares of Common Stock through Samsara BioCapital, L.P., where he is a managing member of Samsara BioCapital GP, LLC, the general partner of Samsara LP. He disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Stakeholder Impact

• Shareholders: The grant of equity compensation to a director aligns their financial interests with the long-term performance of the company, potentially benefiting shareholders through improved governance and strategic decisions.
• Employees: While not directly impacting all employees, the compensation structure for directors can set a precedent for equity-based incentives within the company, potentially influencing broader compensation philosophies.

Next Steps

• Continued service by Srinivas Akkaraju to Scholar Rock Holding Corp. is required for the vesting of the granted Restricted Stock Units and stock options.
• The Issuer's next Annual Meeting will serve as an alternative vesting trigger for both the RSUs and stock options.

Key Dates

Recommendation

Keywords

Scholar Rock Holding Corp, SRRK, Srinivas Akkaraju, Form 4, Insider Trading, Restricted Stock Units, RSU, Stock Options, Equity Compensation, Director Compensation, Beneficial Ownership, Samsara BioCapital